Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Mol PGM. Critically reviewing impact of regulatory actions, not just FDA's. Pharmacoepidemiol Drug Saf 2014;23:105. [DOI: 10.1002/pds.3509] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2013] [Accepted: 07/30/2013] [Indexed: 11/11/2022]

For:	Mol PGM. Critically reviewing impact of regulatory actions, not just FDA's. Pharmacoepidemiol Drug Saf 2014;23:105. [DOI: 10.1002/pds.3509] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2013] [Accepted: 07/30/2013] [Indexed: 11/11/2022]

Number	Cited by Other Article(s)
1	Decrease in Switches to ‘Unsafe’ Proton Pump Inhibitors After Communications About Interactions with Clopidogrel. Clin Drug Investig 2017;37:787-794. [DOI: 10.1007/s40261-017-0536-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Decrease in Switches to ‘Unsafe’ Proton Pump Inhibitors After Communications About Interactions with Clopidogrel. Clin Drug Investig 2017;37:787-794. [DOI: 10.1007/s40261-017-0536-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]